Hampton, NJ-based Celldex Therapeutics, Inc. CLDX is a biopharmaceutical company developing immunotherapy technologies and other cancer-targeting biologics. The company is still in development stage and does not have any …
With this pivotal question firmly in mind, let's consider why the bears might, in fact, be right about this speculative cancer stock. After the late-stage flame out of its brain cancer vaccine Rintega last year, Celldex's antibody-drug conjugate …
symbol=ALNY On Tuesday, shares in Hampton, New Jersey headquartered Celldex Therapeutics Inc. recorded a …
CLDX) today announced that Margo Heath-Chiozzi, M.D., has joined the Company as Senior Vice President, Regulatory …
Nasdaq7mon
Agenus ... Celldex's vaccine failure was one of 2016's worst: Rintega performed as expected, but the control group receiving standard chemo did unusually well. It looks like the heavy losses left bruises that the market isn't ready to …
It looks like the heavy losses left bruises that the market isn't ready to forget, and the stock has yet to recover. That could change before too long. Celldex has another candidate approaching the finish line, called glemba, that is entirely …
Celldex Therapeutics, Inc. CLDX is expected to report third-quarter 2016 results on Nov 3. Celldex’s performance has been encouraging with a three-quarter average positive surprise of 4.85%. In the last reported quarter, the company recorded …